Vimseltinib: First Approval.
- Published in:
- Drugs, 2025, v. 85, n. 7, p. 985, doi. 10.1007/s40265-025-02191-z
- By:
- Publication type:
- Article
Works matching DE "PHARMACEUTICAL industry"
Results: 5000
1
2
Applying linked data approaches to pharmacology: Architectural decisions and implementation.
- Published in:
- Semantic Web (1570-0844), 2014, v. 5, n. 2, p. 101, doi. 10.3233/SW-2012-0088
- By:
- Publication type:
- Article
3
Publishing and interlinking the Global Health Observatory datasetTowards increasing transparency in Global Health.
- Published in:
- Semantic Web (1570-0844), 2013, v. 4, n. 3, p. 315, doi. 10.3233/SW-130102
- By:
- Publication type:
- Article
4
Challenges for the recovery movement in the US: Will its light reach the darkest corners?
- Published in:
- Clinical Psychology Forum, 2015, n. 268, p. 7, doi. 10.53841/bpscpf.2015.1.268.7
- By:
- Publication type:
- Article
5
eBGF: An Enhanced Geometric Hierarchical Representation for Protein Modeling and Rapid Self-Collision Detection.
- Published in:
- Computer-Aided Design & Applications, 2009, v. 6, n. 5, p. 625, doi. 10.3722/cadaps.2009.625-638
- By:
- Publication type:
- Article
6
LITIGATION, REFORM, AND THE OPIOID CRISIS: FROM MDL TO BANKRUPTCY.
- Published in:
- Touro Law Review, 2025, v. 40, n. 2, p. 365
- By:
- Publication type:
- Article
7
Starting the Conversation: The Need for a Pre-Launch "Skinny Labeling" Dispute Resolution System.
- Published in:
- Missouri Law Review, 2025, v. 90, n. 2, p. 615
- By:
- Publication type:
- Article
8
Prioritizing Equity: A Call to Implement Freely Available and Accessible Patient-Reported Outcome Measures in Paediatric Gender-Affirming Care.
- Published in:
- Paediatrics & Child Health (1205-7088), 2025, v. 38, n. 2, p. 100, doi. 10.1093/pch/pxaf009
- By:
- Publication type:
- Article
9
Internal Communication in Pharmaceutical Companies: A Case Study of Portuguese Companies during the Pandemic of COVID-19.
- Published in:
- Communication & Society, 2025, v. 38, n. 1, p. 1, doi. 10.15581/003.38.1.002
- By:
- Publication type:
- Article
10
Regulatory framework and challenges for live biotherapeutic products in Taiwan.
- Published in:
- Journal of Food & Drug Analysis, 2025, v. 33, n. 2, p. 97, doi. 10.38212/2224-6614.3540
- By:
- Publication type:
- Article
11
The Botanical Biohacker: An Interview with Andrew Miles.
- Published in:
- Journal of Chinese Medicine (JCM), 2025, n. 138, p. 35
- By:
- Publication type:
- Article
12
On the origin of non-specific binders isolated in the selection of phage display peptide libraries.
- Published in:
- Frontiers in Microbiology, 2025, p. 1, doi. 10.3389/fmicb.2025.1571679
- By:
- Publication type:
- Article
13
The 10th Chinese National NIR Conference held in Beijing.
- Published in:
- NIR News, 2024, v. 35, n. 7/8, p. 12, doi. 10.1177/09603360251314837
- By:
- Publication type:
- Article
14
Beitrags- und Literaturübersicht.
- Published in:
- Zeitschrift für Stoffrecht, 2025, v. 22, n. 2, p. 186
- Publication type:
- Article
15
Social Determinants of Health: State of the art, precarious employment and labor markets, racial and ethnic oppression, pharmaceutical industry, war and global health.
- Published in:
- International Journal of Social Determinants of Health & Health Services, 2025, v. 55, n. 3, p. 235, doi. 10.1177/27551938251346942
- By:
- Publication type:
- Article
16
The path to scalable continuous manufacturing: Insights from a full-scale pilot for parenterals.
- Published in:
- TechnoPharm, 2025, v. 15, n. 2, p. 68
- By:
- Publication type:
- Article
17
The Innovation/Access Tradeoff, Part 1000.
- Published in:
- Journal of Law, Medicine & Ethics, 2025, v. 53, n. 1, p. 164, doi. 10.1017/jme.2025.55
- By:
- Publication type:
- Article
18
Antioxidant activity and composition of Clinopodium tomentosum in wet and dry extraction.
- Published in:
- Revista Mexicana de Ciencias Agrícolas, 2025, v. 16, n. 13, p. 1, doi. 10.29312/remexca.v16i3.3630
- By:
- Publication type:
- Article
19
Suzetrigine.
- Published in:
- American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 635, doi. 10.1093/ajhp/zxaf054
- Publication type:
- Article
20
Participants in the FDA's Biomarker Qualification Program.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 80, doi. 10.1002/cpt.3661
- By:
- Publication type:
- Article
21
ДИГИТАЛНИТЕ ТЕХНОЛОГИИ ВЪВ ФАРМАЦИЯТА – ПРЕДИМСТВА И БАРИЕРИ ЗА ПРИЛОЖЕНИЕТО ИМ.
- Published in:
- Management & Education / Upravlenie i Obrazovanie, 2025, v. 21, n. 6, p. 254
- By:
- Publication type:
- Article
22
ДИГИТАЛНИТЕ ТЕХНОЛОГИИ ВЪВ ФАРМАЦИЯТА – ПРЕДИМСТВА И БАРИЕРИ ЗА ПРИЛОЖЕНИЕТО ИМ.
- Published in:
- Management & Education / Upravlenie i Obrazovanie, 2025, v. 21, n. 1, p. 254
- By:
- Publication type:
- Article
23
An Underappreciated Lesson Derived From Biotechnology.
- Published in:
- GEN Biotechnology, 2025, v. 4, n. 3, p. 111, doi. 10.1089/genbio.2025.0020
- By:
- Publication type:
- Article
24
Applying Machine Learning Techniques to Predict Drug-Related Side Effect: A Policy Brief.
- Published in:
- Inquiry (00469580), 2025, v. 62, p. 1, doi. 10.1177/00469580251335805
- By:
- Publication type:
- Article
25
FDA Reports Amneal Pharmaceutical's Nationwide Recall of Sulfamethoxazole/Trimethoprim Tablets.
- Published in:
- ONS Voice, 2025, p. N.PAG
- Publication type:
- Article
26
Why the Pharmaceutical Industry Needs Implementation Science for Sustainable Innovation.
- Published in:
- Pharmaceutical Medicine, 2025, v. 39, n. 3, p. 147, doi. 10.1007/s40290-025-00566-x
- By:
- Publication type:
- Article
27
Cost and Duration of Clinical Trials in Drug Development by Japanese Pharmaceutical Companies.
- Published in:
- Pharmaceutical Medicine, 2025, v. 39, n. 3, p. 199, doi. 10.1007/s40290-025-00558-x
- By:
- Publication type:
- Article
28
Artificial Intelligence: Applications in Pharmacovigilance Signal Management.
- Published in:
- Pharmaceutical Medicine, 2025, v. 39, n. 3, p. 183, doi. 10.1007/s40290-025-00561-2
- By:
- Publication type:
- Article
29
비만 약물치료의 최신지견.
- Published in:
- Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2025, v. 68, n. 5, p. 321, doi. 10.5124/jkma.25.0058
- By:
- Publication type:
- Article
30
Editorial Board.
- Published in:
- 2014
- Publication type:
- Index
31
Editorial Collaborators.
- Published in:
- 2013
- Publication type:
- Editorial
32
Accelerating access to medical products in the Eastern Mediterranean Region.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
33
Bibliometrics analysis and knowledge mapping of pertussis vaccine research: trends from 1994 to 2023.
- Published in:
- Infection, 2025, v. 53, n. 3, p. 1001, doi. 10.1007/s15010-024-02414-7
- By:
- Publication type:
- Article
34
Efficient micropropagation, genetic validation and phytochemical profiling of Rumex hastatus D. Don- an edible medicinal herb of Western Himalayas.
- Published in:
- In Vitro Cellular & Developmental Biology Plant, 2025, v. 61, n. 2, p. 369, doi. 10.1007/s11627-025-10526-4
- By:
- Publication type:
- Article
35
Modern biomedicine in global economy and Ukraine.
- Published in:
- Socrates Almanac, 2017, p. 11
- By:
- Publication type:
- Article
36
Synthesis of α‐Aryl and α‐Heteroaryl 4‐Silyloxy Piperidines via a One‐Pot Negishi Cross‐Coupling Approach.
- Published in:
- Chemistry - A European Journal, 2025, v. 31, n. 31, p. 1, doi. 10.1002/chem.202500863
- By:
- Publication type:
- Article
37
IN-VITRO COMPARATIVE EVALUATION OF BRANDED AND GENERIC FUROSEMIDE40MG TABLET.
- Published in:
- Advances in Pharmacology & Toxicology, 2024, v. 24, n. 2, p. 69
- By:
- Publication type:
- Article
38
NKure and CRISPR Partners to Develop Of-the-Shelf CAR T Therapy in India.
- Published in:
- Indian Practitioner, 2025, v. 78, n. 5, p. 41
- Publication type:
- Article
39
J&J MedTech, Qure.ai Partner for Early Lung Cancer Detection.
- Published in:
- Indian Practitioner, 2025, v. 78, n. 5, p. 40
- Publication type:
- Article
40
EMA approved orphan medicines since the implementation of the orphan legislation.
- Published in:
- Orphanet Journal of Rare Diseases, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13023-025-03756-7
- By:
- Publication type:
- Article
41
It's Time to Break Up: Dynamics Surrounding Young-Established Firm Alliance Duration.
- Published in:
- Production & Operations Management, 2025, v. 34, n. 6, p. 1276, doi. 10.1177/10591478241279551
- By:
- Publication type:
- Article
42
Advances in the biosynthesis of tetraacetyl phytosphingosine, a key substrate of ceramides.
- Published in:
- Synthetic & Systems Biotechnology, 2025, v. 10, n. 1, p. 1, doi. 10.1016/j.synbio.2024.07.005
- By:
- Publication type:
- Article
43
Determination of Chlorpheniramine Maleate in its Pharmaceutical Preparations Using Homemade Turbidity Flow Injection Analyzer.
- Published in:
- Baghdad Science Journal, 2025, v. 22, n. 5, p. 1451, doi. 10.21123/bsj.2024.10244
- By:
- Publication type:
- Article
44
Chemical Composition of the Leaf Essential Oil of Tritaxis glabella and Its Free-Radical Scavenging Activity.
- Published in:
- Chemistry of Natural Compounds, 2025, v. 61, n. 3, p. 603, doi. 10.1007/s10600-025-04716-0
- By:
- Publication type:
- Article
45
Green Supply Chain Integration and Sustainable Performance in Pharmaceutical Industry of China: A Moderated Mediation Model.
- Published in:
- Systems, 2025, v. 13, n. 5, p. 388, doi. 10.3390/systems13050388
- By:
- Publication type:
- Article
46
Deciphering the Risk–Return Dynamics of Pharmaceutical Companies Using the GARCH-M Model.
- Published in:
- Risks, 2025, v. 13, n. 5, p. 87, doi. 10.3390/risks13050087
- By:
- Publication type:
- Article
47
Marine-Derived Compounds Combined with Nanoparticles: A Focus on the Biomedical and Pharmaceutical Sector.
- Published in:
- Marine Drugs, 2025, v. 23, n. 5, p. 207, doi. 10.3390/md23050207
- By:
- Publication type:
- Article
48
LETTERS.
- Published in:
- Pulse International, 2025, v. 26, n. 10, p. N.PAG
- By:
- Publication type:
- Article
49
Need for life cycle assessment of pharmaceuticals for kidney healthcare.
- Published in:
- Clinical & Experimental Nephrology, 2025, v. 29, n. 6, p. 702, doi. 10.1007/s10157-025-02647-2
- By:
- Publication type:
- Article
50
Development and Validation of a Sensitive LC-MS/MS Method for the Determination of N-Nitroso-Atenolol in Atenolol-Based Pharmaceuticals.
- Published in:
- Separations (2297-8739), 2025, v. 12, n. 5, p. 122, doi. 10.3390/separations12050122
- By:
- Publication type:
- Article